Stage-Associated Efficacy of Systemically Administered Neural Stem Cell-Derived Exosomes in Ischemic Stroke through the Prevention of Cx43 Degradation
ACS Applied Materials & Interfaces · 04.11.2026 · 18 (43) · 58769-58782
DOI: 10.1021/acsami.6c08991 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, online erschienen am 21.10.2026. Verfasst von Ze-Feng Yang und 7 weiteren Autor:innen. Beteiligte Einrichtung: State Laboratory of Advanced Drug Delivery Systems of Zhejiang Province, School of Pharmacy, Zhejiang University, Hangzhou310058, China. Hauptthemen laut MEDLINE: Exosomes, Connexin 43, Neural Stem Cells, Ischemic Stroke. Die Arbeit nennt 44 Literaturangaben. Gefördert von: Natural Science Foundation of Zhejiang Province, Fundamental Research Funds for the Central Universities, National Natural Science Foundation of China (NSFC).
Themen: Schlaganfall
Abstract (Originalsprache)
Ischemic stroke pathology is highly dynamic, making the optimal timing for biological interventions highly elusive. This study investigated the stage-associated therapeutic efficacy of neural stem cell-derived exosomes (NSC-Exos) for cerebral ischemia–reperfusion. The in vivo evaluations identified a restricted therapeutic window closely associated with the temporal evolution of the ischemic microenvironment. Early exosome intervention (4 or 24 h post-ischemia) significantly reduced infarct volume, restored blood–brain barrier integrity, and improved neurological functional recovery. In contrast, delayed administration (48 h) failed to reduce the mortality rate and provide meaningful neuroprotection. To examine the molecular basis of this time dependence, we integrated temporal proteomic profiling of the ischemic penumbra with small RNA sequencing of NSC-Exos. The analytical and functional data suggest that early NSC-Exo delivery transfers miR-9-5p to suppress Nedd4 expression, thereby restoring the Connexin 43 protein pool and stabilizing the astrocytic network to halt initial microenvironmental collapse. Collectively, this study underscores the critical importance of intervention timing and provides a potential translational strategy for utilizing NSC-Exos as a targeted, stage-specific therapy in acute ischemic stroke.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Laboratory of Advanced Drug Delivery Systems of Zhejiang Province, School of Pharmacy, Zhejiang University, Hangzhou310058, China.
- Key Laboratory of Drug Monitoring and Control of Zhejiang Province, National Narcotics Laboratory Zhejiang Regional Center, Hangzhou310053, China.
- Dr. Li Dak Sum & Yip Yio chin Center for Stem Cell and Regenerative Medicine, Zhejiang University, Hangzhou310058, China.
ORCID-Profile: Jian-Qing Gao
Förderung
- Natural Science Foundation of Zhejiang Province
- Fundamental Research Funds for the Central Universities
- National Natural Science Foundation of China (NSFC)
Zitieren
APA
Yang, Z. F., Li, L., Qiu, X. Y., Li, Y. S., Zheng, J. J., Dong, Y. F., Jiang, X. C., & Gao, J. Q. (2026). Stage-Associated Efficacy of Systemically Administered Neural Stem Cell-Derived Exosomes in Ischemic Stroke through the Prevention of Cx43 Degradation. ACS Applied Materials & Interfaces, 18(43), 58769-58782. https://doi.org/10.1021/acsami.6c08991
Vancouver
Yang ZF, Li L, Qiu XY, Li YS, Zheng JJ, Dong YF, et al. Stage-Associated Efficacy of Systemically Administered Neural Stem Cell-Derived Exosomes in Ischemic Stroke through the Prevention of Cx43 Degradation. ACS Applied Materials & Interfaces. 2026;18(43):58769-58782. doi:10.1021/acsami.6c08991
BibTeX
@article{Yang2026,
author = {Yang, Ze-Feng and Li, Lu and Qiu, Xiao-Yu and Li, Yao-Sheng and Zheng, Juan-Juan and Dong, Yun-Fei and Jiang, Xin-Chi and Gao, Jian-Qing},
title = {Stage-Associated Efficacy of Systemically Administered Neural Stem Cell-Derived Exosomes in Ischemic Stroke through the Prevention of Cx43 Degradation},
journal = {ACS Applied Materials & Interfaces},
year = {2026},
volume = {18},
number = {43},
pages = {58769--58782},
doi = {10.1021/acsami.6c08991}
}
EUVIMED